TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
MEDIROM Healthcare Technologies ( (MRM) ) has shared an update.
On September 18, 2025, MEDIROM Healthcare Technologies Inc. announced that the Japan Ground Self-Defense Force (JGSDF) has adopted its remote health monitoring system, REMONY, powered by the MOTHER Bracelet. This system addresses the need for continuous health monitoring in extreme conditions without the need for recharging, enhancing the safety and operational efficiency of JGSDF personnel. The adoption of REMONY marks a significant advancement in health management technology for the military, potentially influencing similar adoptions in other sectors.
The most recent analyst rating on (MRM) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on MEDIROM Healthcare Technologies stock, see the MRM Stock Forecast page.
Spark’s Take on MRM Stock
According to Spark, TipRanks’ AI Analyst, MRM is a Neutral.
The overall stock score is driven by a mixed financial performance with strong revenue growth but significant profitability and cash flow challenges. Technical analysis indicates a positive trend, while valuation suggests the stock is undervalued. The absence of earnings call and corporate events data limits further insights.
To see Spark’s full report on MRM stock, click here.
More about MEDIROM Healthcare Technologies
MEDIROM Healthcare Technologies Inc. is a health-tech company based in Tokyo, Japan, focusing on digital preventative healthcare solutions. Its subsidiary, MEDIROM MOTHER Labs Inc., develops the MOTHER Bracelet, a recharge-free smart tracker, and offers customizable health management solutions across various sectors.
Average Trading Volume: 2,714,992
Technical Sentiment Signal: Hold
Current Market Cap: $14.62M
See more insights into MRM stock on TipRanks’ Stock Analysis page.